+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Breast Cancer Screening Market - Global Forecast 2026-2032- Product Image
Breast Cancer Screening Market - Global Forecast 2026-2032- Product Image
New

Breast Cancer Screening Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 189 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011427
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The breast cancer screening market is experiencing rapid transformation as technological advancements, changing patient expectations, and evolving care models reshape clinical and operational strategies. Senior leaders must adapt to new opportunities and challenges driven by digitalization, procurement shifts, and innovation in breast imaging.

Market Snapshot: Breast Cancer Screening Market Growth and Outlook

The global breast cancer screening market is on a steady upward trajectory, expanding from USD 5.69 billion in 2025 to USD 6.09 billion in 2026 and projected to reach USD 9.75 billion by 2032. The compound annual growth rate (CAGR) of 8.00% demonstrates sustained investment in advanced screening technologies and growing utilization in established as well as emerging economies. This expansion is fueled by increased awareness, ongoing research focus, and evolving reimbursement policies that prioritize preventive healthcare strategies.

Scope & Segmentation

This report provides in-depth coverage of critical areas impacting business strategy and market participation:

  • Imaging Modalities: Examines established and emerging solutions, including two-dimensional digital mammography, three-dimensional tomosynthesis, both contrast and non-contrast magnetic resonance imaging (MRI), molecular breast imaging (notably breast-specific gamma imaging and scintimammography), thermography, and automated and handheld ultrasound options.
  • Age Cohorts: Analyzes tailored screening pathways and utilization trends for under 40, 40–49, 50–69, and 70+ year-old populations, providing insight into risk distribution and clinical needs within each group.
  • Deployment Preferences: Distinguishes between cloud-hosted solutions—ranging from web-based platforms to software-as-a-service—and on-premise deployments, reflecting regional differences in IT infrastructure, integration, and regulatory requirements.
  • Care Settings: Covers ambulatory care centers, specialist and primary care clinics, independent and networked diagnostic centers, and public and private hospitals. Each setting is examined for procurement dynamics and clinical implementation patterns.
  • Regional Coverage: Offers comparative analysis across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with a focus on reimbursement models, diffusion of advanced modalities, and infrastructure readiness.

Key Takeaways for Strategic Decision-Making

  • Artificial intelligence and advanced image interpretation tools are improving diagnostic accuracy, optimizing radiologist workloads, and scaling operational capacity across care networks.
  • Three-dimensional tomosynthesis and progressive MRI protocols are shifting provider preference, especially in complex cases and high-risk patient groups.
  • Broader adoption of molecular and ultrasound-based screening is increasing access, particularly in areas where mammography effectiveness may be limited by breast density or geographic barriers.
  • Patient-centric approaches, including risk-based protocols and personalized screening, are influencing both device design and service delivery models.
  • Cloud-driven solutions enable centralized reviews and facilitate collaboration across sites, though some organizations continue to invest in on-premise platforms to address data governance requirements.
  • Vendors are developing flexible commercial strategies like leasing, bundled services, and agreements linked to measurable clinical outcomes to address budget constraints and economic fluctuations.

Tariff Impact: Navigating Shifting Procurement Economics

Ongoing tariff changes affecting medical imaging equipment and components are altering procurement economics. Providers encounter rising costs and modified buying timelines, while manufacturers are accelerating regional sourcing, shifting production closer to key markets, and customizing product offerings to mitigate import complexities. In this climate, platforms that emphasize service delivery and software value are helping to buffer capital pressures. Stakeholders are also exploring alternatives such as refurbished equipment or consumption-based contracts, with these choices influenced by local reimbursement systems and organizational flexibility.

Methodology & Data Sources

Insights in this report are based on structured interviews with a broad spectrum of industry, healthcare provider, and vendor experts, comprehensive analysis of clinical literature, and assessments of regulatory and technical documents. Quantitative findings derive from deployment and utilization data, cross-referenced by expert panels to ensure accuracy and relevance.

Why This Report Matters

  • Enables executive teams to stay ahead of technology and policy shifts, strengthening capital planning and procurement processes.
  • Identifies regional and specialist segment opportunities, giving leaders the tools to align business offerings with local clinical and economic drivers.
  • Delivers clear insights into resilient supply chain practices and strategic partnerships between providers and technology vendors, supporting long-term market access and operational stability.

Conclusion

The evolving breast cancer screening landscape will be defined by advanced imaging, adaptive workflow models, and flexible procurement approaches. Organizations that integrate technology adoption with regional and regulatory priorities will achieve sustained value and deliver improved patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Breast Cancer Screening Market, by Technology
8.1. 2D Mammography
8.1.1. Analog
8.1.2. Digital
8.2. 3D Tomosynthesis
8.3. Magnetic Resonance Imaging
8.3.1. Contrast Enhanced
8.3.2. Non Contrast
8.4. Molecular Breast Imaging
8.4.1. Breast Specific Gamma Imaging
8.4.2. Scintimammography
8.5. Thermography
8.6. Ultrasound
8.6.1. Automated
8.6.2. Handheld
9. Breast Cancer Screening Market, by Age Group
9.1. 40 To 49
9.2. 50 To 69
9.3. 70 And Above
9.4. Under 40
10. Breast Cancer Screening Market, by Delivery Mode
10.1. Cloud
10.1.1. Software As A Service
10.1.2. Web Based
10.2. On Premise
11. Breast Cancer Screening Market, by End User
11.1. Ambulatory Care Centers
11.2. Clinics
11.2.1. Primary Care Clinics
11.2.2. Specialty Clinics
11.3. Diagnostic Centers
11.3.1. Chain Centers
11.3.2. Independent Centers
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Breast Cancer Screening Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Breast Cancer Screening Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Breast Cancer Screening Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Breast Cancer Screening Market
16. China Breast Cancer Screening Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Canon Medical Systems Corporation
17.6. Carestream Health, Inc.
17.7. Fujifilm Holdings Corporation
17.8. GE HealthCare
17.9. Hologic, Inc.
17.10. Konica Minolta, Inc.
17.11. Koninklijke Philips N.V.
17.12. NanoString Technologies, Inc.
17.13. NIRAMAI Health Analytix Private Limited
17.14. Novartis AG
17.15. Oncocyte Corporation
17.16. OncoStem Diagnostics Pvt. Ltd
17.17. Pfizer Inc.
17.18. Prelude Corporation
17.19. Quest Diagnostics Incorporated
17.20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17.21. Shimadzu Corporation
17.22. Siemens Healthineers AG
17.23. Syantra Inc.
17.24. Vayyar Imaging, Ltd.
List of Figures
FIGURE 1. GLOBAL BREAST CANCER SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BREAST CANCER SCREENING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BREAST CANCER SCREENING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BREAST CANCER SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BREAST CANCER SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ANALOG, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ANALOG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ANALOG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIGITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 3D TOMOSYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 3D TOMOSYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 3D TOMOSYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CONTRAST ENHANCED, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CONTRAST ENHANCED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CONTRAST ENHANCED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY NON CONTRAST, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY NON CONTRAST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY NON CONTRAST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST SPECIFIC GAMMA IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST SPECIFIC GAMMA IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST SPECIFIC GAMMA IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SCINTIMAMMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SCINTIMAMMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SCINTIMAMMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY THERMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY THERMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY THERMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HANDHELD, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 40 TO 49, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 40 TO 49, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 40 TO 49, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 50 TO 69, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 50 TO 69, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 50 TO 69, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 70 AND ABOVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 70 AND ABOVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 70 AND ABOVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY UNDER 40, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY UNDER 40, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY UNDER 40, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE AS A SERVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE AS A SERVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE AS A SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY WEB BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY WEB BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY WEB BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRIMARY CARE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRIMARY CARE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CHAIN CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CHAIN CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CHAIN CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY INDEPENDENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY INDEPENDENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 165. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 166. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 167. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 168. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 169. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 170. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 171. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 172. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 175. EUROPE BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 189. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 191. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 192. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 193. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 194. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 195. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 196. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 197. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 198. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 200. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 201. AFRICA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 218. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 219. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 220. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 221. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 222. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 223. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 224. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 225. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 227. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 228. ASEAN BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 229. GCC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. GCC BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 231. GCC BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 232. GCC BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 233. GCC BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 234. GCC BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 235. GCC BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 236. GCC BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 237. GCC BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 238. GCC BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. GCC BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 240. GCC BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 241. GCC BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 255. BRICS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. BRICS BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 257. BRICS BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 258. BRICS BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 259. BRICS BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 260. BRICS BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 261. BRICS BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 262. BRICS BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 263. BRICS BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 264. BRICS BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 265. BRICS BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 266. BRICS BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 267. BRICS BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 268. G7 BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 269. G7 BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 270. G7 BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 271. G7 BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 272. G7 BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 273. G7 BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 274. G7 BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 275. G7 BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 276. G7 BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 277. G7 BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. G7 BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 279. G7 BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 280. G7 BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 281. NATO BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 282. NATO BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 283. NATO BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 284. NATO BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 285. NATO BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 286. NATO BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 287. NATO BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 288. NATO BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 289. NATO BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 290. NATO BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 291. NATO BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 292. NATO BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 293. NATO BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 294. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 296. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 297. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 298. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 299. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 300. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 301. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 302. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 303. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 304. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 305. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 306. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 307. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 308. CHINA BREAST CANCER SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 309. CHINA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 310. CHINA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 311. CHINA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 312. CHINA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2032 (USD MILLION)
TABLE 313. CHINA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 314. CHINA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 315. CHINA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 316. CHINA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 317. CHINA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 318. CHINA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 319. CHINA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 320. CHINA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Breast Cancer Screening market report include:
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Fujifilm Holdings Corporation
  • GE HealthCare
  • Hologic, Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • NanoString Technologies, Inc.
  • NIRAMAI Health Analytix Private Limited
  • Novartis AG
  • Oncocyte Corporation
  • OncoStem Diagnostics Pvt. Ltd
  • Pfizer Inc.
  • Prelude Corporation
  • Quest Diagnostics Incorporated
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Syantra Inc.
  • Vayyar Imaging, Ltd.

Table Information

Report AttributeDetails
No. of Pages189
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.09 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.75 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Computer-aided Detection for Breast Cancer Screening Market - Global Forecast 2025-2030 - Product Image

Computer-aided Detection for Breast Cancer Screening Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Breast Cancer Screening Device Market - Global Forecast 2025-2030 - Product Image

Breast Cancer Screening Device Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Global Breast Cancer Screening Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Breast Cancer Screening Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 115 Pages
  • Global
From
Breast Cancer Imaging Market Size, Share & Trends Analysis Report by Stage of Care (Diagnostic, Monitoring), End Use (Hospitals, Breast Care Centers), Technology and Region with Growth Forecasts, 2025-2033 - Product Image

Breast Cancer Imaging Market Size, Share & Trends Analysis Report by Stage of Care (Diagnostic, Monitoring), End Use (Hospitals, Breast Care Centers), Technology and Region with Growth Forecasts, 2025-2033

  • Report
  • 140 Pages
  • Global
From
Next-Generation Breast Cancer Diagnostic and Screening Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Next-Generation Breast Cancer Diagnostic and Screening Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 187 Pages
  • Global
From

About the Breast Cancer Screening Market

The Breast Cancer Screening market is a key component of Women's Health. It is a preventative measure that helps to detect breast cancer in its early stages, when it is most treatable. Screening typically involves mammography, which is an X-ray imaging test that can detect changes in the breast tissue. Other screening methods include clinical breast exams, breast ultrasounds, and MRI scans. The Breast Cancer Screening market is a growing industry, with many companies offering services to women. These companies provide a range of services, from mammography to MRI scans, to help women detect breast cancer early. Companies in the Breast Cancer Screening market include Breastlink, Breast Cancer Diagnostics, and Breast Health Solutions. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.